Atypical chemokine receptor 2: a brake against Kaposi's sarcoma aggressiveness

Inflammatory chemokines are instrumental players in cancer-related inflammation contributing to numerous steps during tumor progression. In Kaposi's sarcoma, we have found that downregulation of the atypical chemokine receptor 2 (ACKR2) by the KRAS/BRAF/ERK pathway profoundly affects the tumor...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncoimmunology
Prif Awduron: Bonecchi, Raffaella, Savino, Benedetta, Caronni, Nicoletta, Celesti, Giuseppe, Mantovani, Alberto, Locati, Massimo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Taylor & Francis 2015
Pynciau:
Author's View
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4353167/
https://ncbi.nlm.nih.gov/pubmed/25964861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.955337
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg